MDMB-5'Br-BUTINACA (5'-Br-MDMB-BUTINACA) is an
indazole
Indazole, also called isoindazole, is a heterocyclic aromatic organic compound. This bicyclic compound consists of the fusion of benzene and pyrazole.
Indazole is an amphoteric molecule which can be protonated to an indazolium cation or deprotona ...
-3-carboxamide based
synthetic cannabinoid
Synthetic cannabinoids, or neocannabinoids, are a class of designer drug molecules that Binding affinity, bind to the same receptors to which cannabinoids (Tetrahydrocannabinol, THC, Cannabidiol, CBD and many others) in cannabis plants attach. Th ...
receptor agonist that has been sold as a
designer drug
A designer drug is a structural or functional analog of a controlled substance that has been designed to mimic the pharmacological effects of the original drug, while avoiding classification as illegal and/or detection in standard drug tests. ...
. It was first identified in Russia in August 2022. It is believed to be synthesized from the "half finished" synthesis precursor
MDMB-5Br-INACA, which is shipped to the destination and then the final synthetic step is completed on arrival.
See also
*
4F-MDMB-BINACA
-MDMB-BINACA (also known as MDMB-4F-BINACA using systematic EMCDDA nomenclature or 4F-MDMB-BUTINACA) is an indazole-based synthetic cannabinoid from the indazole-3-carboxamide family. It should not be confused with the amantadine analogue 4F-A ...
*
6-Bromopravadoline
WIN 54,461 (6-Bromopravadoline) is a drug that acts as a potent and selective inverse agonist for the cannabinoid receptor CB2.
See also
* ADB-5'Br-PINACA
* AM-630 (6-Iodopravadoline)
* WIN 48,098 (Pravadoline)
* WIN 55,212-2
WIN 55,212-2 i ...
*
ADB-PINACA
ADB-PINACA is a cannabinoid designer drug that is an ingredient in some synthetic cannabis products. It is a potent agonist of the CB1 receptor and CB2 receptor with EC50 values of 0.52 nM and 0.88 nM respectively. Like MDMB-FUBIN ...
*
ADB-5'F-BUTINACA
ADB-5'F-BUTINACA is an indazole-3-carboxamide based synthetic cannabinoid receptor agonist. It was synthesised as part of investigations into related compounds such as ADB-5'Br-BUTINACA and MDMB-5'Br-BUTINACA, and confirmed that fluorination of ...
*
ADB-5'Br-BUTINACA
*
ADB-5'Br-PINACA
ADB-5'Br-PINACA (5'-Br-ADB-PINACA) is an indazole-3-carboxamide based synthetic cannabinoid receptor agonist that has been sold as a designer drug. It was first identified in Abu Dhabi in September 2022 but has subsequently been found in the US ...
*
ADSB-FUB-187
ADSB-FUB-187 is an indazole-based synthetic cannabinoid. It is a potent agonist of the CB1 receptor with a binding affinity of ''K''i = 0.09 nM and an EC50 of 1.09 nM. It was originally developed by Pfizer in 2009, being ex ...
*
MDMB-BINACA
*
MDMB-5'Br-4en-PINACA
References
Cannabinoids
Designer drugs
Bromoarenes
Amides
Tert-butyl compounds
Indazolecarboxamides
Methyl esters
{{cannabinoid-stub